Physician profile
Michele Chavez
NPI 1184655433
$1,373.38
in general payments reported to CMS, 2019-2025
9 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.90 · 2022: $71.24 · 2023: $665 · 2024: $344 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $917.17 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $190.58 | 2023 | |
| Sumitomo Pharma America, INC. | $138.46 | 2023 | Myfembree |
| Abbvie INC. | $34.85 | 2022 | |
| Organon LLC | $25.00 | 2024 | |
| Pfizer INC. | $18.09 | 2024 | |
| Shield Therapeutics INC | $17.93 | 2024 | |
| Bard Peripheral Vascular, INC. | $15.90 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $15.40 | 2025 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.